Members |
targetComponentId |
Carcinoid tumor of ileum |
Well-differentiated neuroendocrine tumor of ileum |
Carcinoid tumor of intestine |
Well-differentiated neuroendocrine tumour of intestine |
Carcinoid tumor of large intestine |
Well-differentiated neuroendocrine tumor of large intestine |
Carcinoid tumor of pancreas |
Neuroendocrine tumor of pancreas (disorder) |
Carcinoid tumor of rectum |
Well-differentiated neuroendocrine tumour of rectum |
Carcinoid tumor of small intestine |
Well-differentiated neuroendocrine tumor of small intestine (disorder) |
Carcinoid tumor of stomach |
Well-differentiated neuroendocrine tumour of stomach |
Carcinoid tumor of uncertain malignant potential |
Well-differentiated neuroendocrine tumor (morphologic abnormality) |
Carcinoma in situ - category |
Carcinoma in situ (morphologic abnormality) |
Carcinoma in situ NOS |
Carcinoma in situ (disorder) |
Carcinoma in situ NOS |
Carcinoma in situ (disorder) |
Carcinoma in situ neoplastic process |
Carcinoma in situ (morphologic abnormality) |
Carcinoma in situ of areola of female breast |
Carcinoma in situ of areola (disorder) |
Carcinoma in situ of areola of male breast |
Carcinoma in situ of areola (disorder) |
Carcinoma in situ of axillary tail of female breast |
Carcinoma in situ of axillary tail of breast |
Carcinoma in situ of central portion of female breast |
Carcinoma in situ of central portion of breast (disorder) |
Carcinoma in situ of ectopic female breast tissue |
Carcinoma in situ of ectopic site of breast (disorder) |
Carcinoma in situ of ectopic male breast tissue |
Carcinoma in situ of ectopic site of breast (disorder) |
Carcinoma in situ of female breast |
Carcinoma in situ of breast |
Carcinoma in situ of lower inner quadrant of female breast |
Carcinoma in situ of lower inner quadrant of breast |
Carcinoma in situ of lower outer quadrant of female breast |
Carcinoma in situ of lower outer quadrant of breast (disorder) |
Carcinoma in situ of male breast |
Carcinoma in situ of breast |
Carcinoma in situ of nipple of female breast |
Carcinoma in situ of nipple (disorder) |
Carcinoma in situ of nipple of male breast |
Carcinoma in situ of nipple (disorder) |
Carcinoma in situ of other and unspecified female genital organs |
Carcinoma in situ of female genital organ |
Carcinoma in situ of other and unspecified female genital organs |
Carcinoma in situ of female genital organ |
Carcinoma in situ of other and unspecified male genital organs |
Carcinoma in situ of male genital organ |
Carcinoma in situ of other and unspecified male genital organs |
Carcinoma in situ of male genital organ |
Carcinoma in situ of skin of other and unspecified parts of face |
Carcinoma in situ of skin of face |
Carcinoma in situ of skin of other and unspecified parts of face |
Carcinoma in situ of skin of face |
Carcinoma in situ of skin of other and unspecified parts of face NOS |
Carcinoma in situ of skin of face |
Carcinoma in situ of upper inner quadrant of female breast |
Carcinoma in situ of upper inner quadrant of breast |
Carcinoma in situ of upper outer quadrant of female breast |
Carcinoma in situ of upper outer quadrant of breast |
Carcinoma in situ tumour |
Carcinoma in situ (disorder) |
Carcinoma in situ, no International Classification of Diseases for Oncology subtype |
Carcinoma in situ (morphologic abnormality) |
Carcinoma liver/biliary system NOS |
Carcinoma liver and/or biliary system (disorder) |
Carcinoma of cervix stage 0 |
Carcinoma in situ of uterine cervix |
Carcinoma of genital organs NOS |
Carcinoma of genital organ (disorder) |
Carcinoma of genital organs NOS |
Carcinoma of genital organ (disorder) |
Carcinoma of male breast |
Carcinoma of breast |
Carcinoma of skin (excluding eyelid, vulva, penis, and melanomas) TNM finding |
American Joint Committee on Cancer allowable value |
Carcinoma resembling breast carcinoma |
Carcinoma (morphologic abnormality) |
Carcinoma, no subtype |
Carcinoma (morphologic abnormality) |
Cardiac access incision |
Incision |
Cardiac arrest, unspecified |
Cardiac arrest (disorder) |
Cardiac arrest, unspecified |
Cardiac arrest (disorder) |
Cardiac dysrhythmia NOS |
Cardiac arrhythmia (disorder) |
Cardiac dysrhythmia NOS |
Cardiac arrhythmia (disorder) |
Cardiac end diastolic volume, function (observable entity) |
Cardiac end-diastolic volume (observable entity) |
Cardiac glycoside adverse reaction |
Adverse reaction to Digitalis glycoside |
Cardiac status not worse than preoperative baseline |
Cardiac status is consistent with or improved from preoperative baseline (finding) |
Cardio-oesophageal X-ray |
Plain X-ray of cardioesophageal junction with contrast |
Cardioesophageal X-ray |
Plain X-ray of cardioesophageal junction with contrast |
Cardiology service |
Cardiology service (qualifier value) |
Cardiomyopathy NOS |
Cardiomyopathy |
Cardiomyopathy NOS |
Cardiomyopathy |
Cardiomyopathy due to drugs and other external agents |
Cardiomyopathy caused by drug |
Cardioplegia perfusion solution |
Cardioplegic solution agent (substance) |
Cardioplegia solution |
Cardioplegic solution agent (substance) |
Cardituberculous cirrhosis |
Cirrhosis of liver |
Care of Hickman catheter |
Care of central venous catheter (regime/therapy) |
Care of body sites |
Care regime |
Care of venous dissection |
Procedure on cardiovascular system |
Care plan |
Care plan (record artifact) |
Care plan |
Care plan (record artifact) |
Care plan |
Care plan (record artifact) |
Cares for mentally handicapped dependent |
Caregiver of dependent with intellectual disability |
Carglumic acid 200mg dispersible tablet |
Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Carglutamic acid 200mg dispersible tablet |
Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Caring environment |
Caring environment (finding) |
Carlavirus group |
Genus Carlavirus (organism) |
Carmellose sodium 0.5% eye drops |
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Carmellose sodium 1% conventional release eye drops |
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Carmellose sodium 1% single-use eye drops |
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Carmustine 7.7mg wafer |
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) |
Carnobacterium piscicola |
Carnobacterium maltaromaticum (organism) |
Carotenosis cutis |
Carotene pigmentation of skin |
Carpal bones X-ray |
Plain X-ray of carpus (procedure) |
Carpal tunnel X-ray |
Plain X-ray of wrist, carpal tunnel view |
Carpenter Waziri syndrome |
X-linked intellectual disability hypotonic face syndrome |
Carvedilol 10mg controlled release capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 10mg prolonged-release oral capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 20mg controlled release capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 20mg prolonged-release oral capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 40mg controlled release capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 40mg prolonged-release oral capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 80mg controlled release capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carvedilol 80mg prolonged-release oral capsule |
Product containing only carvedilol in oral dose form (medicinal product form) |
Carya illinoensis |
Carya illinoinensis (organism) |
Carya illinoensis diagnostic allergen extract |
Carya illinoinensis diagnostic allergen extract (product) |
Carya illinoensis specific immunoglobulin E antibody measurement |
Carya illinoinensis specific immunoglobulin E antibody measurement (procedure) |
Casmerodius albus |
Ardea alba (organism) |
Casting or strapping procedure |
Stabilization |
Casualty,not due to war, of accident NOS |
Accidental event (event) |
Cat allergy vaccine |
Cat allergy vaccine (product) |
Cat scratch disease |
Cat scratch disease |
Cataract |
Opacity |
Cataract NOS |
Cataract |
Cataract NOS |
Cataract |
Catarrhal pneumonia |
Pneumonia |
Catechin 15% topical ointment |
Catechin only product |